Vineti is a company purpose-built for personalized therapies. From the beginning, Vineti’s founders have understood the challenges that biotech and pharmaceutical innovators face in developing personalized therapies. The emerging ecosystem of cell therapies, gene therapies, and personalized cancer vaccines requires new enabling technologies to align and manage production processes and the patient journey. Our patent pending Personalized Therapy Management (PTM) platform provides the next-generation technology that advanced therapies need.
Why Work With Us
After closing Series C financing in early 2020, we are in hyper growth. We are looking for talented change-makers to join us as we continue to advance our cutting edge software, who are driven by our mission, and will be partners with us in shaping the healthcare-tech industry. As a member of the Vineti team, we can promise you the opportunity to collaborate alongside smart and driven people, with endless opportunities to grow your many skills.
Co-Founder and CEO
Before co-founding Vineti, Amy focused on healthcare new business creation for GE Ventures/ healthymagination. Prior to GE, Amy was Chief Business Officer at Navigenics, a genomics company sold to Life Technologies in 2012. She was co-founder and Executive Director of Proposition 71, California’s $3B stem cell research initiative passed in 2004, as well as Chief of Staff at the resulting state grant oversight agency. Amy holds an MBA and MA/BA from Stanford University. She was named a 2016 Health Innovator Fellow by the Aspen Institute.